The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
Jetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015). The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology, 51, 585–588. https://doi.org/10.1016/j.psyneuen.2014.11.002
Abstract Created by REACH
10 male Canadian military personnel with PTSD participated in a study investigating the efficacy of nabilone capsules (a synthetic cannabinoid) in treating PTSD-associated nightmares. 50% of the participants who received nabilone versus 1% of those who received the placebo reported much improved nightmares.
Research summaries convey terminology used by the scientists who authored the original research article; some terminology may not align with the federal government's mandated language for certain constructs.
Cookie Preferences
We use cookies to enhance your browsing experience. Please review our Privacy Statement for more information.
Necessary cookies: Essential for the website to function properly.
Analytics cookies: Help us understand how visitors interact with our website.